Latest News :
Indiana CE requirements have changed. More...

 Home | About Us | FAQ | Privacy Statement | Site Map | Contact Us


  Also visit   

Home > CE for Doctors > Course Description  
TITLE Evidence-Based Treatment of Newly Diagnosed Glaucoma and Ocular Hypertension for the Practicing Optometrist
ABSTRACT: When clinicians approach the management of a patient with an ailment, it is often the provider's working assumption that the 'standard of care' for the treatment of this condition actually benefits the patient. Preferably, there also exists sound scientific evidence to support this. Until relatively recently, there was a dearth of quality scientific inquiry into the effects of treatment of various diseases including open angle glaucoma. In fact, there were several published studies that strongly suggested that, treated or not, patients with open angle glaucoma get worse over time. So what is the point in treating this condition? Recent evidence has shed light on this issue but, as often is the case in science, it asks as many questions as it answers. The following is a synopsis of two major scientific studies of open angle glaucoma and ocular hypertension. These studies were intended to assist us in our clinical decision-making and to further explore the natural history, risk factors and treatments of open angle glaucoma.  Author(s): Mitchell W. Dul, OD, MS, FAAO
Company: SUNY College of Optometry
Release Date: Unknown
CE Credits: 2
Price: $30.00
CE Format: Online text/photos




Problem with a course or test?  Click HERE to request help from the CE provider. 

Help make more useful! After you complete a course, please take a moment to rate your experience with the online course.

Rate this course: Poor
Course name:
Email address (optional):
 Receive CE updates & news



 Home | About Us | FAQ | Privacy Statement | Site Map | Contact Us


Copyright 2006-2009 - All Rights Reserved. Best viewed in 1024x768 resolution.
Any unauthorized reproduction or distribution of the contents of this website is prohibited.